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Abstract
The GMO Panel has previously assessed the single events Bt11, 59122, MIR604, 1507 and GA21 as well
as different stacked events corresponding to combinations of these events and no safety concerns were
identiﬁed. In its assessment of the ﬁve-event maize stack Bt11 9 59122 9 MIR604 9 1507 9 GA21
(application EFSA-GMO-DE-2011-99), the GMO Panel also assessed all the subcombinations of these
events not previously assessed, including some for which little or no experimental data were provided,
including the three-event stack Bt11 9 1507 9 GA21. In line with Article 5 of the decision for
authorisation of application EFSA-GMO-DE-2011-99, the European Commission received from Syngenta
information on the levels of the newly expressed proteins in subcombination Bt11 9 1507 9 GA21 and
tasked EFSA to analyse these data and to indicate whether they have an impact on the previously
issued opinion on the ﬁve-event stack Bt11 9 59122 9 MIR604 9 1507 9 GA21 and its
subcombinations. Analyses of the levels of the newly expressed proteins Cry1Ab, PAT, Cry1F and
mEPSPS showed that there is no indication of an interaction between the events combined in maize
Bt11 9 1507 9 GA21 that would affect the levels of the newly expressed proteins. Thus, the GMO
Panel is of the opinion that the new information for maize Bt11 9 1507 9 GA21 does not alter the
conclusions of the scientiﬁc opinion on application EFSA-GMO-DE-2011-99.
© 2017 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf
of European Food Safety Authority.
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1. Introduction
The EFSA Panel on Genetically Modiﬁed Organisms (GMO) has previously assessed the single events
Bt11, 59122, MIR604, 1507 and GA21 as well as different stacked events corresponding to
combinations of these events (Table 1). In the framework of the risk assessment of the ﬁve-event
stack Bt11 9 59122 9 MIR604 9 1507 9 GA21, the GMO Panel also assessed all 20 subcombinations
of this stacked event not previously assessed such as the three-event stack maize
Bt11 9 1507 9 GA21 and concluded that that they are expected to be as safe as the ﬁve-event stack
maize (application EFSA-GMO-DE-2011-99, EFSA GMO Panel, 2016). The three-event stack maize,
Bt11 9 1507 9 GA21, was obtained by conventional crossing and data on the levels of the newly
expressed proteins were produced and provided by the applicant. The GMO Panel assessed this
information to determine whether it has an impact on the opinion previously issued by the European
Food Safety Authority (EFSA) on the ﬁve-event stack Bt11 9 59122 9 MIR604 9 1507 9 GA21 and its
20 subcombinations.
1.1. Background and Terms of Reference as provided by the requestor
The completion of the risk assessment of the ﬁve-event stack maize event
Bt11 9 59122 9 MIR604 9 1507 9 GA21 and its subcombinations independently of their origin
(application EFSA-GMO-DE-2011-99 of Syngenta), was followed by the decision of the European
Commission authorising the food and feed containing, consisting and produced from GM maize
Bt11 9 59122 9 MIR604 9 1507 9 GA21 and subcombinations under Regulation (EC) 1829/2003
(Commission implementing decision 2017/1209/EU). As laid down in Article 5 of this decision, the
authorisation holder is requested to provide information on the expression levels of the newly
expressed proteins for any subcombinations that were to be created by targeted breeding approaches
and commercialised.
Table 1: GMO Panel scientiﬁc opinions on the single maize events Bt11, 1507, MIR604, 1507 and
GA21 and stacks containing these single events
Event Application EFSA Scientiﬁc Opinions
Bt11 C/F/96/05.10
EFSA-GMO-RX-Bt11
EFSA-M-2012–0232
EFSA (2005a), EFSA GMO Panel (2012), EFSA
(2009a), EFSA GMO Panel (2012)
59122 EFSA-GMO-NL-2005-23
EFSA-GMO-RX-003
EFSA GMO Panel (2013a,b), EFSA GMO
Panel (2017a)
MIR604 EFSA-GMO-UK-2005-11 EFSA (2009b)
1507 C/NL/00/10
C/ES/01/01,2001/18/EC
EFSA-GMO-NL-02
EFSA-GMO-RX-1507
EFSA-GMO-RX-001
EFSA (2004), EFSA (2005b), EFSA (2005c), EFSA
(2009c), EFSA GMO Panel (2017b)
GA21 EFSA-GMO-UK-2005-19
EFSA-GMO-RX-GA21
EFSA-GMO-RX-005
EFSA (2007), EFSA GMO Panel (2017c)
Bt11 3 GA21 EFSA-GMO-UK-2007-49
EFSA-GMO-DE-2009-66
EFSA GMO Panel (2009a), EFSA GMO Panel (2015)
MIR604 3 GA21 EFSA-GMO-UK-2007-48
EFSA-GMO-DE-2009-66
EFSA GMO Panel (2010a), EFSA GMO Panel (2015)
59122 3 1507 EFSA-GMO-DE-2005-15
EFSA-GMO-CZ-2008-62
EFSA-GMO-BE-2013-118
EFSA GMO Panel (2009b), EFSA GMO
Panel (2010b), EFSA GMO Panel (2017d)
Bt11 3 MIR604 EFSA-GMO-UK-2007-50
EFSA-GMO-DE-2009-66
EFSA GMO Panel (2010c), EFSA GMO Panel (2015)
Bt11 3 GA21 3 MIR604 EFSA-GMO-UK-2008-56
EFSA-GMO-DE-2009-66
EFSA GMO Panel (2010d), EFSA GMO Panel (2015)
Bt11 3 59122 3 MIR604 3
1507 3 GA21 (and 20
subcombinations)
EFSA-GMO-DE-2011-99 EFSA GMO Panel (2016)
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On 18 August 2017, Syngenta informed the European Commission that the subcombination
Bt11 9 1507 9 GA21 will be produced by targeted breeding for commercialisation and in line with the
Commission implementing decision 2017/1209/EU, sent information on the levels of the newly
expressed proteins for this subcombination to the European Commission. On 15 September 2017, the
European Commission requested EFSA to assess this information and indicate whether it has an impact
on the opinion for application EFSA-GMO-DE-2011-99 adopted by EFSA.
2. Data and methodologies
2.1. Data
The applicant provided a study which included data on the levels of the newly expressed proteins,
Cry1Ab, phosphinothricin acetyltransferase (PAT), Cry1F and mutated 5-enolpyruvylshikimate-3-
phosphate-synthase (mEPSPS) in the three-event stack and the corresponding singles Bt11, 1507 and
GA21.1 The study contains data derived from plants grown in three locations in one season and is
therefore in line with the latest GMO Panel guidelines for the risk assessment of genetically modiﬁed
(GM) plants (EFSA GMO Panel, 2011) and also with the requirements as laid down in Regulation (EU)
No 503/20132. On 27 October 2017, the GMO Panel requested further information on the statistical
methodology applied to analyse the data on the levels of the newly expressed proteins. The applicant
provided the requested information on 22 November 2017.3
2.2. Methodologies
In delivering this statement, the GMO Panel took into account the information provided by the
applicant and carried out its scientiﬁc risk assessment based on the appropriate principles described in
its guidelines for the risk assessment of GM plants (EFSA GMO Panel, 2011) and Regulation (EU)
No 503/2013.
2.2.1. New information for the subcombination maize Bt11 3 1507 3 GA21
submitted as part of the current mandate
Plants were grown under ﬁeld conditions in USA in 2014 (three locations, ﬁve replicate plots).1 The
levels of Cry1Ab, PAT, Cry1F and mEPSPS proteins in the three-event stack maize and the three single
events were quantiﬁed by enzyme-linked immunosorbent assay (ELISA). Protein levels were
determined in leaves (V6 and R1 stages), roots (V6 and R1 stages), whole plants (V6 and R1 stages),
pollen (R1 stage) and in grain (R6 and senescence stages) (Annex A).
3. Assessment
The GMO Panel assessed the levels of the newly expressed proteins in the three-event stack and
the respective singles. The levels of the newly expressed proteins Cry1Ab, PAT, Cry1F and mEPSPS
were similar in the three-event stack Bt11 9 1507 9 GA21 and the corresponding single events Bt11,
1507 and GA21, in all tissues, except for the expected differences for the PAT protein levels resulting
from the combination of single events Bt11 and 1507 both producing PAT protein in the three-event
stack maize. For mEPSPS, quantitative data were not available for all tested tissues because in some
tissues the expression levels were below the limit of detection (LOD) and limit of quantiﬁcation (LOQ)
(Annex A). Based on the available data, there is no indication of an interaction between the events
that would affect the levels of the newly expressed proteins in this three-event stack maize
Bt11 9 1507 9 GA21. This is consistent with the conclusions of the GMO Panel for application EFSA-
GMO-DE-2011-99.
1 Comparison of Transgenic Protein Concentrations in Bt11 9 TC1507 9 GA21, Event Bt11, Event TC1507, and Event GA21
Maize Tissues Report No: TK0212355.
2 Commission Implementing Regulation (EU) No 503/2013 of 3 April 2013 on applications for authorisation of genetically
modiﬁed food and feed in accordance with Regulation (EC) No 1829/2003 of the European Parliament and of the Council and
amending Commission Regulations (EC) No 641/2004 and (EC) No 1981/2006. OJ L157, 8.6.2013, p. 1–48.
3 Additional information: 22/11/17.
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4. Conclusions
Based on the analysis of the data provided, the GMO Panel considers that the new information for
maize Bt11 3 1507 3 GA21 does not alter the conclusions of the scientiﬁc opinion on application
EFSA-GMO-DE-2011-99 (EFSA GMO Panel, 2016).
Documentation provided to EFSA
1) Letter from the European Commission, received on 15 September 2017, concerning a request to
analyse additional information related to the application for authorisation of food and feed
containing, consisting and produced from genetically modiﬁed maize Bt11 9 59122 9
MIR604 9 1507 9 GA21 and genetically modiﬁed maizes combining two or three of the events
under Regulation 1829/2003 (Commission Decision 2017/1209/EU).
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Abbreviations
Cry crystal protein
ELISA enzyme-linked immunosorbent assay
GM genetically modiﬁed
GMO EFSA Panel on Genetically Modiﬁed Organisms
LOD limit of detection
LOQ limit of quantiﬁcation
mEPSPS mutated 5-enolpyruvylshikimate-3-phosphate-synthase
PAT phosphinothricin acetyltransferase
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Annex A – Means, standard deviations and ranges (n = 15) of protein
levels in plant tissues from different developmental stages (lg/g dry
weight) from maize events Bt11 3 1507 3 GA21, Bt11, 1507 and GA21.
Plants were not treated with intended herbicides
Bt11 3 1507 3 GA21 Bt11 1507 GA21
Cry1Ab
Leaf (V6) 133.0(a)  57.5(b)
(81.9–207)(c)
118.0  57.5
(75.0–205.0)
Leaf (R1) 50.747.4
(14.8–80.9)
41.5  47.4
(18.3–92.0)
Root(V6) 46.7  14.6
(30.5–59.8)
46.1  14.6
(35.6–59.5)
Root(R1) 21.4  13.6
(7.65–35.5)
19.7  13.6
(10.4–26.3)
Whole plant (V6) 109.0  35.7
(0.702–183)
97.0  35.7
(60.2–144)
Whole plant (R1) 27.4  27.4
(9.30–55.6)
23.0  27.4
(9.3–55.6)
Pollen (R1) 0.14  0.051
(0.105–0.199)
0.125  0.051
(0.0899–0.189)
Grain (R6) 4.5  0.54
(3.67–5.59)
3.95  0.54
(3.23–4.84)
Grain
(senescence)
4.0  1.571
(2.65–4.96)
3.68  1.571
(2.52–4.81)
PAT(d)
Leaf (V6) 5.59  2.028
(2.02–7.92)
0.383  0.1737
(0.0849–0.594)
5.86  1.649
(1.91–8.78)
Leaf (R1) 8.15  2.434
(0.139–0.931)
0.506  0.1792
(0.142–0.695)
7.98  1.942
(4.82–11.2)
Root(V6) 0.772  0.3024
(0.310–1.36)
0.503  0.2351
(0.230–0.933)
0.358  0.1329
(0.149–0.545)
Root(R1) 0.822  0.459
(< LOD–1.50)
0.590  0.3293
(< LOD–0.976)
0.367  0.245
(< LOD–0.717)
Whole plant (V6) 3.56  0.786
(2.52–5.63)
0.577  0.2466
(0.139–0.931)
3.46  0.764
(1.34–4.38)
Whole plant (R1) 3.41  2.201
(0.851–8.14)
0.583  0.2247
(0.336–1.06)
3.24  1.456
(1.42–6.35)
Pollen (R1) < LOD < LOD < LOD
Grain (R6) ND
(< LOD–0.129)
ND
(< LOD–0.0612)
ND
(< LOD–0.0572)
Grain
(senescence)
ND
(< LOD–0.0532)
ND
(< LOD–0.0423)
ND
(< LOD–< LOQ)
Cry1F
Leaf (V6) 28.7  10.7
(20.5–37.5)
29.3  10.7
(18.6–40.0)
Leaf (R1) 22.5  5.3
(15.8–25.7)
22.1  5.3
(14.9–27.7)
Root(V6) 9.69  5.1
(6.99–13.3)
8.96  5.1
(3.21–12.5)
Root(R1) 6.57  7.54
(1.65–11.6)
6.85  7.54
(2.76–11.7)
Whole plant (V6) 19.1  7.0
(11.5–23.4)
18.4  7.0
(11.8–24.0)
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Bt11 3 1507 3 GA21 Bt11 1507 GA21
Whole plant (R1) 13.0  3.1
(8.43–16.5)
15.4  3.1
(11.8–22.8)
Pollen (R1) 43.1  11.5
(34.1–53.2)
43.4  11.5
(36.4–51.1)
Grain (R6) 7.52  7.53
(4.91–14.6)
8.44  7.53
(5.05–14.0)
Grain
(senescence)
8.34  4.38
(6.16–12.1)
8.53  4.38
(6.23–12.5)
mEPSPS
Leaf (V6) 22.3  34.98
(< LOQ–56.5)
33.3  34.98
(< LOQ–73.6)
Leaf (R1) ND (< LOD–60.1) ND (< LOQ–89.0)
Root(V6) ND (< LOD–< LOQ) ND (< LOD–< LOQ)
Root(R1) ND (< LOD–< LOQ) ND (< LOQ–21.9)
Whole plant (V6) ND (< LOD–57.3) ND (< LOQ–52.3)
Whole plant (R1) 31.1  22.35
(< LOD–57.7)
50.6  22.35
(22.7–73.9)
Pollen (R1) 146.0  15.7
(110.0–177.0)
115.0  15.7
(90.1–130.0
Grain (R6) ND (< LOD–< LOQ) ND (< LOQ–8.49)
Grain
(senescence)
ND (< LOD–< LOQ) ND (< LOQ–6.25)
LOD: limit of detection; LOQ: limit of quantiﬁcation; PAT: phosphinothricin acetyltransferase; mEPSPS: mutated 5-enolpyruvylshikimate-
3-phosphate-synthase; ND: Not determined.
(a): Mean.
(b): Standard deviation.
(c): Range.
(d): The standard deviation (SD) values reported for PAT levels in Bt11, 1507 and Bt11 9 1507 9 GA21 were determined with
descriptive statistics. The SD values for Cry1Ab, Cry1F and mEPSPS levels were determined with analysis of variance.
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